Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America by Weber Donna M, Chen Christine, Niesvizky Ruben, Wang Michael, Belch Andrew, Stadtmauer Edward A, Siegel David, Borrello Ivan, Rajkumar S Vincent, Chanan-Khan Asher Alban, Lonial Sagar, Yu Zhinuan, Patin John, Olesnyckyj Marta, Zeldis Jerome B, Knight Robert D, Multiple Myeloma (009) Study Investigators in The New England journal of medicine (2007).

[PMID: 18032763] PubMed


Lenalidomide, an oral immunomodulatory drug that is similar to thalidomide but has a different safety profile, has clinical activity in relapsed or refractory multiple myeloma.

[ hide abstract ]

Discussed In Paper


Rx Annotations

No dosing information annotated.